Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity Statement

v3.26.1
Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Unearned Compensation
Noncontrolling Interest
Beginning balance (shares) at Dec. 31, 2024   24,950,261        
Beginning balance at Dec. 31, 2024 $ 10,125,538 $ 24,950 $ 57,845,289 $ (47,639,894)   $ (104,807)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (shares) 35,000 35,000        
Exercise of stock options $ 38,500 $ 35 38,465      
Stock based compensation expense 40,833   40,833      
Distributions to noncontrolling interest (32,889)         (32,889)
Net (loss) income (660,489)     (659,922)   (567)
Ending balance (shares) at Mar. 31, 2025   24,985,261        
Ending balance at Mar. 31, 2025 9,511,493 $ 24,985 57,924,587 (48,299,816)   (138,263)
Beginning balance (shares) at Dec. 31, 2025   29,846,479        
Beginning balance at Dec. 31, 2025 $ 21,472,612 $ 29,847 78,216,467 (55,888,649) $ (712,019) (173,034)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (shares) 58,750 58,750        
Exercise of stock options $ 54,500 $ 59 54,441      
Stock based compensation expense 131,666   82,486   49,180  
Net (loss) income (2,118,655)     (2,120,573)   1,918
Ending balance (shares) at Mar. 31, 2026   29,905,229        
Ending balance at Mar. 31, 2026 $ 19,540,123 $ 29,906 $ 78,353,394 $ (58,009,222) $ (662,839) $ (171,116)